CompletedPhase 4ACTRN12611000639921
Comparison between two clomiphene citrate protocols for induction of ovulation in clomiphene resistant Polycystic ovarian disease.
Sponsor
Mervat Sheikh Elarab Elsedeek Omran
Enrollment
200 participants
Start Date
Jan 1, 2009
Study Type
Interventional
Conditions
Summary
The primary purpose of the study is to test if either doubling the dose of clomiphene citrate or doubling the duration would make previously unresponsive patients respond and ovulate, and to compare the efficacy of either approach.
Eligibility
Sex: FemalesMin Age: 20 YearssMax Age: 35 Yearss
Inclusion Criteria1
- married, nulligravida, polycystic ovarian disease, resistant to clomiphene citrate drug in previous cycle/s
Exclusion Criteria1
- previous pelvic surgery, other causes of infertility, BMI>35
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
clomiphene citrate oral tablets 100 mg daily for 10 days, starting within 5 days of induced menses.
clomiphene citrate oral tablets 100 mg daily for 10 days, starting within 5 days of induced menses.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000639921